fxs_header_sponsor_anchor

News

NZD/USD registers three-day losing streak as US and China jostle over virus spread

  • NZD/USD drops over 0.50% during the initial hours of trading.
  • US diplomats cite intelligence reports to allege China for the virus outbreak, the dragon nation considers them as a bluff.
  • Gilead’s Remdesivir will be available during this week.
  • A light calendar will keep trade/virus updates as the key catalysts.

NZD/USD declines 0.65% to 0.6025 amid the early Asian session on Monday. In doing so, the kiwi pair registers a three-day losing streak amid the US-China tussle surrounding the coronavirus (COVID-19) outbreak.

Having initially attacked China’s inability (selective) to report the virus outbreak to the World Health Organization (WHO) on time, US President Donald Trump’s recent allegations take clues from an intelligence report to back the allegations. The Republican leader previously suggested that the experiments in the laboratory of virology in Wuhan were responsible for the virus outbreak.

Read: US President Donald Trump: “Intelligence has just reported to me that I was correct” on China

Not only US President Trump but Secretary of State Mike Pompeo also joined the line to attack China over its mishandling of the virus, which in turn became the global challenge.

In a reaction to the allegations, China’s Global Times mentioned that Secretary Pompeo's anti-China bluff strategy reveals an all-or-nothing mentality to fool US voters. The editorial piece also said, “The truth is that Pompeo does not have any evidence, and during Sunday's interview, he was bluffing.”

While the trade-war risk is currently weighing on the markets, news that Gilead’s Remdesivir, a championed drug for the virus, fails to please the traders.

As a result, the risk aversion wave exerts downside pressure on the commodity-linked currency and also weighs on the US stock futures, S&P 500 Futures down more than 1.0% by press time.

Given the lack of major data/events from New Zealand, traders will keep eyes on the trade/virus news for fresh impetus. However, second-tier inflation, jobs and housing data from Australia may offer intermediate moves to the kiwi pair.

Technical analysis

An ascending trend line from March 23, 2020, close to 0.6025/20 acts as the near-term strong support, a break of which can drag the quote to 0.5910, comprising the low marked on April 23. Meanwhile, an upward sloping resistance line from March 27, around 0.6200, could question the pair’s recovery moves beyond 0.6100 and the previous month top surrounding 0.6175.

Additional important levels

Overview
Today last price 0.6062
Today Daily Change 0.0000
Today Daily Change % 0.00
Today daily open 0.6062
 
Trends
Daily SMA20 0.603
Daily SMA50 0.6058
Daily SMA100 0.6309
Daily SMA200 0.6355
 
Levels
Previous Daily High 0.6128
Previous Daily Low 0.6046
Previous Weekly High 0.6176
Previous Weekly Low 0.5991
Previous Monthly High 0.6176
Previous Monthly Low 0.5843
Daily Fibonacci 38.2% 0.6077
Daily Fibonacci 61.8% 0.6097
Daily Pivot Point S1 0.603
Daily Pivot Point S2 0.5997
Daily Pivot Point S3 0.5948
Daily Pivot Point R1 0.6112
Daily Pivot Point R2 0.6161
Daily Pivot Point R3 0.6194

 

 

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2026 FOREXSTREET S.L., All rights reserved.